NPPB and hydrops fetalis: Notably, Ezekowitz et al. demonstrated that vericiguat had the most significant effects on reducing cardiovascular death and HF hospitalization in those with chronic HFrEF when entry-level NT-proBNP was < 8000 pg/ml [78].